What the FDA labels say about taking them together
Fenofibric acid and rosuvastatin
Rosuvastatin's FDA label of September 4, 2026 names fenofibric acid in its drug interactions section; fenofibric acid's label does not name rosuvastatin itself but warns about its class (Statins). The rosuvastatin label: “Fenofibrates Prevention or Management: Consider if the benefit of using fibrates concomitantly with CRESTOR outweighs the increased risk of myopathy and rhabdomyolysis.”
Check it at the source: the fenofibric acid FDA label on DailyMed (effective August 2, 2025, Aurobindo Pharma Limited); the rosuvastatin FDA label on DailyMed (effective September 4, 2026, ScieGen Pharmaceuticals, Inc.).
What does the fenofibric acid label say about rosuvastatin?
Fenofibric acid's label does not name rosuvastatin itself; it warns about its class (Statins):
Fenofibric acid label, drug interactionsThe risk of myopathy and rhabdomyolysis is increased with concomitant use of fibrates with statins.
Fenofibric acid label, drug interactionsConsider if the benefit of using fenofibric acid delayed-release capsules concomitantly with statin therapy outweighs the increased risk of myopathy and rhabdomyolysis.
Source: FDA drug label (FENOFIBRIC ACID), Aurobindo Pharma Limited, effective August 2, 2025 (SPL set 9ad201de-fa62-4c49-bc61-ee09b9ba434c), via openFDA; the full label on DailyMed
What does the rosuvastatin label say about fenofibric acid?
Rosuvastatin label, drug interactionsFenofibrates (e.g., fenofibrate and fenofibric acid) Prevention or Management: Consider if the benefit of using fibrates concomitantly with rosuvastatin outweighs the increased risk of myopathy and rhabdomyolysis.
Source: FDA drug label (Crestor, NDA021366), AstraZeneca Pharmaceuticals LP, effective April 29, 2026 (SPL set 325a5d0e-9a72-4015-9fcd-1655fb504cee), via openFDA
Source: FDA drug label (Rosuvastatin), ScieGen Pharmaceuticals, Inc., effective September 4, 2026 (SPL set ee4933c5-0d97-494d-ac0f-2083e0100836), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Fenofibric acid | Rosuvastatin | |
|---|---|---|
| Labeled for | High cholesterol, High triglycerides | Heart attack and coronary artery disease, High cholesterol, High triglycerides, Stroke prevention |
| Boxed warning | No | No |
| Pharmacy cost (NADAC) | $0.286 per capsule 135 mg capsule | $0.0692 per tablet 40 mg tablet |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once